期刊
BIOPHYSICAL JOURNAL
卷 94, 期 2, 页码 411-423出版社
CELL PRESS
DOI: 10.1529/biophysj.106.98590
关键词
-
类别
资金
- NHLBI NIH HHS [P01 HL078931, P50 HL53219] Funding Source: Medline
The L-type Ca current (I-Ca,I-L), essential for normal cardiac function, also regulates dynamic action potential (AP) properties that promote ventricular fibrillation. Blocking I-Ca,I-L can prevent ventricular fabrillation, but only at levels suppressing contractility. We speculated that, instead of blocking I-Ca,I-L, modifying its shape by altering kinetic features could produce equivalent anti-fibrillatory effects without depressing contractility. To test this concept experimentally, we overexpressed a mutant Ca-insensitive calmodulin (CaM1234) in rabbit ventricular myocytes to inhibit Ca-dependent ICa,L inactivation, combined with the ATP-sensitive K current agonist pinacidil or I-Ca,I-L blocker verapamil to maintain AP duration (APD) near control levels. Cell shortening was enhanced in pinacidil-treated myocytes, but depressed in verapamil-treated myocytes. Both combinations flattened APD restitution slope and prevented APD alternans, similar to I-Ca,I-L blockade. To predict the arrhythmogenic consequences, we simulated the cellular effects using a new AP model, which reproduced flattening of APD restitution slope and prevention of APD/Ca-i transient alternans but maintained a normal Ca-i transient. In simulated two-dimensional cardiac tissue, these changes prevented the arrhythmogenic spatially discordant APD/Ca-i transient alternans and spiral wave breakup. These findings provide a proof-of-concept test that I-Ca,I-L can be targeted to increase dynamic wave stability without depressing contractility, which may have promise as an anti. brillatory strategy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据